Epidemiology of cypress pollen allergy in Montpellier.

BACKGROUND Cupressaceae pollen allergy is a worldwide winter pollinosis. Exposure to cypress pollen has increased enormously during recent decades, and cypress pollen allergy has become a major health problem, especially in Mediterranean countries. OBJECTIVES We aimed to evaluate the prevalence of cypress pollen sensitization and allergy in the Montpellier area and the symptoms presented by sensitized patients. METHODS We included all 6185 consecutive patients who were referred to our center for any allergic disorder during a 36-month period. For each patient, we evaluated skin prick test results, allergy symptoms, pulmonary function test results, and the need for allergen immunotherapy. RESULTS We found that 20.7% of patients were sensitized to cypress pollen and 46.4% presented symptoms during the pollen season. The main symptoms were rhinoconjunctivitis and asthma. Oral allergy syndrome to peach was detected in 4% of sensitized and symptomatic patients. Allergen immunotherapy was necessary to control symptoms in 57.9% of cases. CONCLUSIONS Cypress pollen allergy is one of the leading causes of respiratory allergy in the Montpellier area. Symptoms are often severe and include pollen-induced asthma. Moreover,many patients need allergen immunotherapy in order to achieve better control of their symptoms.

[1]  J. Sastre,et al.  Molecular cloning and characterization of Cup a 4, a new allergen from Cupressus arizonica. , 2010, Biochemical and biophysical research communications.

[2]  F. D. de Benedictis,et al.  Complementary roles for lipid and protein allergens in triggering innate and adaptive immune systems , 2008, Allergy.

[3]  M. Lombardero,et al.  Understanding patient sensitization profiles in complex pollen areas: a molecular epidemiological study , 2008, Allergy.

[4]  D. Charpin,et al.  Immunotherapy with an Aluminum Hydroxide-Adsorbed Juniperus ashei Foreign Pollen Extract in Seasonal Indigenous Cypress Pollen Rhinoconjunctivitis , 2007, International Archives of Allergy and Immunology.

[5]  D. Charpin,et al.  Personal risk factors for cypress pollen allergy , 2005, Allergy.

[6]  C. Pichot,et al.  Allergy to cypress pollen , 2005, Allergy.

[7]  P. Bousquet,et al.  Latex is not essential in a standardized skin prick test battery , 2005, Allergy.

[8]  V. del Pozo,et al.  Cloning and expression of a major allergen from Cupressus arizonica pollen, Cup a 3, a PR‐5 protein expressed under polluted environment , 2004, Allergy.

[9]  R. Ariano,et al.  Allergenic Relevance of Cupressus arizonica Pollen Extract and Biological Characterization of the Allergoid , 2002, International Archives of Allergy and Immunology.

[10]  L. Corazzi,et al.  The biology of cypress allergy , 2002, Allergy.

[11]  G. Passalacqua,et al.  Prevalence of allergy to Cypress , 2002, Allergy.

[12]  J. Bousquet,et al.  Immunotherapy with keyhole lampet hemocyanin‐conjugated decapeptide vaccine in cypress pollen allergy , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  R. Panzani.  L'allergie respiratoire aux pollens de conifères , 1962 .

[14]  D. Ordman.  Cypress pollinosis in South Africa : a study of seasonal hay-fever and allergic conjunctivitis occurring in the winter-spring period , 1921 .

[15]  E. Enrique,et al.  Cupressus arizonica pollen: a new pollen involved in the lipid transfer protein syndrome? , 2011, Journal of investigational allergology & clinical immunology.

[16]  O. Gulbahar,et al.  Prevalence of cypress pollen sensitization and its clinical importance in Izmir, Turkey, with cypress allergy assessed by nasal provocation. , 2008, Journal of investigational allergology & clinical immunology.

[17]  M. Lombardero,et al.  Degree of olive pollen exposure and sensitization patterns. Clinical implications. , 2007, Journal of investigational allergology & clinical immunology.